Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009
Take action
Contact the company
📍Recalling firmLegacy Pharmaceutical Packaging LLC13480 Lakefront Dr · Earth City, MO 63045-1516
✎ GovInfoNow plain-language explainer
Legacy Pharmaceutical Packaging LLC is recalling one lot of Lorazepam, 0.5 mg tablets because the labeling contains incorrect or missing lot and expiration date information. The affected product was distributed by Major Pharmaceuticals in Livonia, MI. This recall involves 1,644 bottles sent to Indiana. Read more at govinfonow.com/recall/48188-legacy-pharmaceutical-packaging-llc-recalls-lorazepam-0-5-mg-tablets.
“Lorazepam Recall: Incorrect Lot/Exp Date Labeling.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48188-legacy-pharmaceutical-packaging-llc-recalls-lorazepam-0-5-mg-tablets. Based on FDA recall #D-580-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-580-2013%22&limit=1).
The FDA announced on March 27, 2013, that Legacy Pharmaceutical Packaging LLC voluntarily recalled Lorazepam 0.5 mg tablets due to labeling errors involving incorrect or missing lot and expiration dates. The recall affects products distributed by Major Pharmaceuticals in Livonia, MI.
How to tell if you have it
Brand: Legacy Pharmaceutical Packaging
Product: Lorazepam 0.5 mg Tablets, 100 count, RX only
NDC: 0904-6007-60
Lot Code: L-04009
Expiration Date: 11/15
Distributor: Major Pharmaceuticals, Livonia, MI
Distribution Area: Indiana (IN)
Units Affected: 1,644 bottles
The hazard
The recall involves Lorazepam Lot # L-04009 with an expiration date of 11/15. The hazard is that the labeling contains incorrect or missing lot and/or expiration dates, according to the FDA.
Context
GovInfoNow's records show Legacy Pharmaceutical Packaging LLC has issued seven other recalls since April 22, 2013. On December 11, 2023, the company recalled Sertraline Tablets due to CGMP deviations regarding inadequate line clearance. A September 24, 2020 recall involved Metformin 1000mg Tablets after foreign tablets were found in bottles. Other recent recalls of similar products include Sandoz Focalin XR 5mg Capsules (June 1, 2026), Haleon Parodontax Mouthwash (December 26, 2025), and American Health Packaging Buprenorphine Tablets (August 19, 2026).
How to tell if you have this one
Check your bottle for Lorazepam, 0.5 mg tablets, 100 count, RX only. Look for NDC 0904-6007-60 and Lot # L-04009. The description notes an expiration date of 11/15, but the hazard is that this information may be incorrect or missing.
Brand
Legacy Pharmaceutical Packaging
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check your medication label
Verify if you have Lorazepam 0.5 mg tablets with NDC 0904-6007-60 and Lot # L-04009.
Contact your pharmacist
Since the remedy is not stated in the record, consult your healthcare provider or pharmacist for instructions on how to proceed with this specific lot.
Where it went and when
Where it was distributed
Distributed in Indiana.
Listed by the agency
Not listed
FDA distribution: “Distribution was made to IN.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Indiana.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-580-2013 (March 27, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-580-2013 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.